A Clinically Validated Diagnostic Second-Generation Sequencing Assay for Detection of Hereditary BRCA1 and BRCA2 Mutations-Reference-Cited by-同舟云学术

A Clinically Validated Diagnostic Second-Generation Sequencing Assay for Detection of Hereditary BRCA1 and BRCA2 Mutations

Published:2013-11 Issue:6 Volume:15 Page:796-809
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Bosdet Ian E.,Docking T. Roderick,Butterfield Yaron S.,Mungall Andrew J.,Zeng Thomas,Coope Robin J.,Yorida Erika,Chow Katie,Bala Miruna,Young Sean S.,Hirst Martin,Birol Inanc,Moore Richard A.,Jones Steven J.,Marra Marco A.,Holt Rob,Karsan Aly

Funder

Genome BC

Provincial Health Services Authority of British Columbia

BC Cancer Foundation

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference45 articles.

1. Inherited susceptibility to common cancers;Foulkes;N Engl J Med,2008

2. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies;Antoniou;Am J Hum Genet,2003

3. Meta-analysis of BRCA1 and BRCA2 penetrance;Chen;J Clin Oncol,2007

4. Genetic/familial high-risk assessment: breast and ovarian;Daly;J Natl Compr Canc Netw,2010

5. Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors;Berliner;J Genet Couns,2007

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing clinical genomic accuracy with panelGC: a novel metric and tool for quantifying and monitoring GC biases in hybridization capture panel sequencing;Briefings in Bioinformatics;2024-07-25

2. BRCA1/2 Testing Landscape in Ovarian Cancer: A Nationwide, Real-World Data Study;Cancers;2024-04-26

3. Target-enhanced whole-genome sequencing (TE-WGS) shows clinical validity equivalent to commercially available targeted oncology panel;2023-12-21

4. Tumour DNA Sequencing;Current Cancer Biomarkers;2023-01

5. Use of Treatment-Focused Tumor Sequencing to Screen for Germline Cancer Predisposition;The Journal of Molecular Diagnostics;2021-09